Auspex Pharmaceuticals (ASPX) Surges on Positive SD-809 Data in Huntington's Disease
Tweet Send to a Friend
Auspex Pharmaceuticals (NASDAQ: ASPX) has resumed trading and is up 59% after the company announced positive topline efficacy and safety ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
